SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-125818
Filing Date
2020-11-16
Accepted
2020-11-16 16:16:11
Documents
80
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2035984-1_10q.htm 10-Q 723545
2 EXHIBIT 31.1 tm2035984d1_ex31-1.htm EX-31.1 10681
3 EXHIBIT 31.2 tm2035984d1_ex31-2.htm EX-31.2 10773
4 EXHIBIT 32.1 tm2035984d1_ex32-1.htm EX-32.1 5479
5 EXHIBIT 32.2 tm2035984d1_ex32-2.htm EX-32.2 5128
6 EXHIBIT 99.1 tm2035984d1_ex99-1.htm EX-99.1 40109
  Complete submission text file 0001104659-20-125818.txt   6871921

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ibio-20200930.xml EX-101.INS 1565355
8 XBRL TAXONOMY EXTENSION SCHEMA ibio-20200930.xsd EX-101.SCH 64852
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ibio-20200930_cal.xml EX-101.CAL 51114
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ibio-20200930_def.xml EX-101.DEF 248578
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibio-20200930_lab.xml EX-101.LAB 453064
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibio-20200930_pre.xml EX-101.PRE 424172
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 201317123
SIC: 2834 Pharmaceutical Preparations